Ad is loading...
INZY
Price
$2.80
Change
+$0.11 (+4.09%)
Updated
Nov 22, 03:18 PM (EDT)
118 days until earnings call
STOK
Price
$11.46
Change
+$0.19 (+1.69%)
Updated
Nov 22, 03:38 PM (EDT)
103 days until earnings call
Ad is loading...

INZY vs STOK

Header iconINZY vs STOK Comparison
Open Charts INZY vs STOKBanner chart's image
Inozyme Pharma
Price$2.80
Change+$0.11 (+4.09%)
Volume$100
CapitalizationN/A
Stoke Therapeutics
Price$11.46
Change+$0.19 (+1.69%)
Volume$100
CapitalizationN/A
INZY vs STOK Comparison Chart
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
INZY vs. STOK commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a Buy and STOK is a Buy.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (INZY: $2.69 vs. STOK: $11.27)
Brand notoriety: INZY and STOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 138% vs. STOK: 43%
Market capitalization -- INZY: $179.23M vs. STOK: $599.06M
INZY [@Biotechnology] is valued at $179.23M. STOK’s [@Biotechnology] market capitalization is $599.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 1 FA rating(s) are green whileSTOK’s FA Score has 0 green FA rating(s).

  • INZY’s FA Score: 1 green, 4 red.
  • STOK’s FA Score: 0 green, 5 red.
According to our system of comparison, STOK is a better buy in the long-term than INZY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 4 TA indicator(s) are bullish while STOK’s TA Score has 4 bullish TA indicator(s).

  • INZY’s TA Score: 4 bullish, 7 bearish.
  • STOK’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, STOK is a better buy in the short-term than INZY.

Price Growth

INZY (@Biotechnology) experienced а -21.57% price change this week, while STOK (@Biotechnology) price change was -19.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was -4.98%, and the average quarterly price growth was +4.01%.

Reported Earning Dates

INZY is expected to report earnings on Mar 20, 2025.

STOK is expected to report earnings on Mar 05, 2025.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STOK($599M) has a higher market cap than INZY($179M). STOK YTD gains are higher at: 114.259 vs. INZY (-36.854). INZY has higher annual earnings (EBITDA): -90.3M vs. STOK (-115.03M). STOK has more cash in the bank: 239M vs. INZY (132M). STOK has less debt than INZY: STOK (2.3M) vs INZY (46.8M). STOK has higher revenues than INZY: STOK (16.7M) vs INZY (0).
INZYSTOKINZY / STOK
Capitalization179M599M30%
EBITDA-90.3M-115.03M79%
Gain YTD-36.854114.259-32%
P/E RatioN/AN/A-
Revenue016.7M-
Total Cash132M239M55%
Total Debt46.8M2.3M2,037%
TECHNICAL ANALYSIS
Technical Analysis
INZYSTOK
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 19 days ago
86%
Bullish Trend 9 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ZDIVX27.720.31
+1.13%
Zacks Dividend Investor
CAFRX8.800.06
+0.69%
Commonwealth Africa
FDTTX25.340.17
+0.68%
Fidelity Advisor Capital Development A
TFFIX76.000.19
+0.25%
Touchstone Focused Instl
PIGRX14.020.01
+0.07%
Putnam International Value C

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-3.58%
BEAM - INZY
56%
Loosely correlated
-3.72%
FATE - INZY
49%
Loosely correlated
-6.76%
ABOS - INZY
49%
Loosely correlated
-2.53%
DNLI - INZY
49%
Loosely correlated
-0.82%
PGEN - INZY
48%
Loosely correlated
+7.91%
More

STOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with NUVB. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then NUVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
-0.35%
NUVB - STOK
52%
Loosely correlated
+4.65%
QTTB - STOK
48%
Loosely correlated
-0.88%
STRO - STOK
47%
Loosely correlated
-5.24%
INZY - STOK
44%
Loosely correlated
-3.58%
DNLI - STOK
41%
Loosely correlated
-0.82%
More